CoChat

Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics

Open access
Peterson, Christine Tara · 2020 · Journal of Evidence-Based Integrative Medicine

The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.

Abstract

Recent data suggest gut microbiota dysbiosis as a contributing factor in neurodegenerative diseases, such as Parkinson's Disease (PD) and Alzheimer's Disease (AD), and these pathologies may manifest via the microbiota-gut-brain-axis, which comprises bidirectional communication through neuroimmune, neuroendocrine, and direct neural pathways such as the vagus nerve. Preclinical and human clinical trial data reveal exciting potential for novel treatment targets and therapeutic modulation with prebiotics, medicinal herbs, probiotics, and synbiotics in health, aging, and neurodegeneration and are reviewed here. While greater insights and characterization of the microbiota-gut-brain axis have been revealed over the past decade, salient questions related to the pathology, pathogenesis and clinical treatment of the axis in the context of both health and neurodegenerative disease remain and are discussed in this review. Future directions such as additional well-controlled, large scale, longitudinal human clinical trials are urgently needed to further elucidate both mechanism and therapeutic opportunity in health, neurological disease, and disease subpopulations to ensure that the next decade ushers the dawn of targeted therapeutic modulation of the microbiota-gut-brain axis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2515690x20957225

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Communication pathways of the microbiota-gut-brain axis. Multiple hard-wired or direct (e.g. ENS and vagus nerve) and indirect (e.g. neurotransmitters, SCFAs, cytokines) communication pathways of the gut-brain axis are modulated by gut microbiota. These routes include the neural pathway (e.g. vagus nerve, ENS, neurotransmitters and neuroactive metabolites such as the SCFA butyrate), immune pathway (e.g. cytokines), and neuroendocrine pathways (e.g. gut hormone secretion such as peptide YY, neuropeptide Y, and glucagon-like peptide-1; cortisol secretion via the hypothalamus pituitary adrenal (HPA) axis). Neuroactive dietary and microbially-produced metabolites modulate the microbiome-gut-brain axis to affect gut-barrier function, hormone secretion from enteroendocrine cells (EECs), neurotransmitter production by gut epithelium and microbiota, and enteric glial signaling which are relevant to neurodegenerative disease. Image was generated with BioRender.
Figure 1. Communication pathways of the microbiota-gut-brain axis. Multiple hard-wired or direct (e.g. ENS and vagus nerve) and indirect (e.g. neurotransmitters, SCFAs, cytokines) communication pathways of the gut-brain axis are modulated by gut microbiota. These routes include the neural pathway (e.g. vagus nerve, ENS, neurotransmitters and neuroactive metabolites such as the SCFA butyrate), immune pathway (e.g. cytokines), and neuroendocrine pathways (e.g. gut hormone secretion such as peptide YY, neuropeptide Y, and glucagon-like peptide-1; cortisol secretion via the hypothalamus pituitary adrenal (HPA) axis). Neuroactive dietary and microbially-produced metabolites modulate the microbiome-gut-brain axis to affect gut-barrier function, hormone secretion from enteroendocrine cells (EECs), neurotransmitter production by gut epithelium and microbiota, and enteric glial signaling which are relevant to neurodegenerative disease. Image was generated with BioRender.CC BY-NC · PubMed Central
Figure 2. Schematic diagram of aspects of PD pathology in the microbiota-gut-brain axis. Gut microbiota and their metabolites may communicate with the vagus nerve through enteroendocrine cells that synapse with vagus nerve terminals through specialized structures called neuropods. Microbial antigens such as LPS may cross the gut epithelium through M cells or areas with increased intestinal permeability to trigger local and systemic inflammation. Pathology may develop within myenteric nerve cell plexus with subsequent inflammation, oxidative stress and thus alpha-synuclein accumulation. The vagus nerve might facilitate the pathological spread of alpha-synuclein aggregates from the ENS to the brain. Image was generated with BioRender.
Figure 2. Schematic diagram of aspects of PD pathology in the microbiota-gut-brain axis. Gut microbiota and their metabolites may communicate with the vagus nerve through enteroendocrine cells that synapse with vagus nerve terminals through specialized structures called neuropods. Microbial antigens such as LPS may cross the gut epithelium through M cells or areas with increased intestinal permeability to trigger local and systemic inflammation. Pathology may develop within myenteric nerve cell plexus with subsequent inflammation, oxidative stress and thus alpha-synuclein accumulation. The vagus nerve might facilitate the pathological spread of alpha-synuclein aggregates from the ENS to the brain. Image was generated with BioRender.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 181 references

Research works printed but not linked: 8

  1. Mazzini L, 2018, J Clin Gastroenterol, 52
  2. Erskine EE, J Mol Biol
  3. Peth-Nui T, 2012, Evid Based Complement Alternat Med, 606424
  4. Borzabadi S, 2018, Arch Iran Med, 21, 289
  5. Singh B, 2016, Indian J Exp Biol, 54, 758
  6. Vaidya AB, 1978, Neurol India, 26, 171
  7. Sangiovanni E, 2017, Neural Plast, 5965371
  8. Ton EMM, 2020, Oxid Med Cell Longev, 14

Cited by

See all 179

Metadata

Authors
Peterson, C. T.
Affiliations
University of California San Diego (US)
Corresponding author
Peterson, Christine Tara
Venue
Journal of Evidence-Based Integrative Medicine
Published
2020-01-01
Volume
25
Pages
2515690X2095722
ISSN
2515-690X (ISSN-L)
OpenAlex
W3094482185
Cited by
160
References
181
Citations by year
2026: 26 · 2025: 31 · 2024: 41 · 2023: 23 · 2022: 28 · 2021: 11
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • Journal of Evidence-Based Integrative Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Chopra Foundation (Fellowship Grant)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
microbiota-gut-brain axis, gut dysbiosis, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, prebiotics, probiotics, synbiotics, medicinal plants, vagus nerve, neuroimmune interactions
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Brain, Humans, Phytotherapy, Parkinson Disease, Plant Extracts, Plants, Medicinal, Enteric Nervous System, Neurodegenerative Diseases, Probiotics, Gastrointestinal Tract, Prebiotics, Synbiotics, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. https://app.cochat.ai/papers/10.1177/2515690x20957225
The paper
Peterson, C. T. (2020). Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. Journal of Evidence-Based Integrative Medicine. https://doi.org/10.1177/2515690x20957225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.